An SRM panel assay targeting 39 tryptic peptides from 30 proteins was used to analyze CSF from a cohort of controls, MCI, and AD in CSF (145), reporting CH3L1 (YKL-40) to be significantly increased in AD compared with controls. The gene discussed is CHI3L1; the disease is Alzheimer disease.